Gain Therapeutics, Inc.GANXNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank57
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-0.64
↑ 25% vs avg
Percentile
P57
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-0.85
Historical baseline
PeriodValueYoY Change
TTM-0.64+28.1%
2024-0.89+48.0%
2023-1.71-15.5%
2022-1.48-8.0%
2021-1.37-356.7%
2020-0.30-15.4%
2019-0.26-36.8%
2018-0.19-